Literature DB >> 2742361

Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease.

H Hurtig1, J Joyce, J R Sladek, J Q Trojanowski.   

Abstract

A 53-year-old physician who had a 10-year history of progressive idiopathic parkinsonism survived for 4 months after an autologous adrenal-medulla-to-right-caudate autograft but he received little clinical benefit. A small number of chromaffin cells in the graft site survived; they expressed neurofilament proteins and chromogranin A, but scant tyrosine hydroxylase. The striatum on both sides showed almost complete loss of [3H]mazindol binding to dopamine-uptake sites; the density of dopamine receptors was decreased adjacent to the transplant but increased rostral to the transplant. These results demonstrate that autografted chromaffin cells can survive for 4 months after transplantation and that related changes in dopamine receptors can be quantified.

Entities:  

Mesh:

Year:  1989        PMID: 2742361     DOI: 10.1002/ana.410250613

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.

Authors:  B Lach; D Grimes; B Benoit; A Minkiewicz-Janda
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  New aspects of neurotransplantation.

Authors:  S Woerly; D J Morassutti
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

Review 3.  Successful survival of grafted transgenic neural plate cells in adult central nervous system environment.

Authors:  K Uchida; A H Roach; M D Kawaja; S Toya
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

4.  Unfavorable outcome of adrenal medullary transplant for Parkinson's disease.

Authors:  L S Forno; J W Langston
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 5.  Cell transplantation for Parkinson's disease: present status.

Authors:  René Drucker-Colín; Leticia Verdugo-Díaz
Journal:  Cell Mol Neurobiol       Date:  2004-06       Impact factor: 5.046

Review 6.  The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine.

Authors:  J N Joyce
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 7.  Evidence for plasticity of the dopaminergic system in parkinsonism.

Authors:  G A Donnan; D G Woodhouse; S J Kaczmarczyk; J E Holder; G Paxinos; P J Chilco; A J Churchyard; R M Kalnins; G C Fabinyi; F A Mendelsohn
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 8.  Cell-based therapies for Parkinson disease—past insights and future potential.

Authors:  Roger A Barker; Janelle Drouin-Ouellet; Malin Parmar
Journal:  Nat Rev Neurol       Date:  2015-08-04       Impact factor: 42.937

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.